NCT00108576View on ClinicalTrials.gov

Divalproex Sodium in the Treatment of PTSD (Post-Traumatic Stress Disorder)

PHASE3CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

August 31, 2005

Study Completion Date

September 30, 2005

Conditions
PTSD
Interventions
DRUG

Divalproex

anticonvulsant; mood stabilizer

OTHER

placebo

Look-a-like placebo

Trial Locations (1)

35404

Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT00108576 - Divalproex Sodium in the Treatment of PTSD (Post-Traumatic Stress Disorder) | Biotech Hunter | Biotech Hunter